-James D Marks Researcher Activity Profile

Research Author Detailed Information 

James D Marks Publication Rate By Year

James D Marks has published 4 paper(s) in 2006, 17 paper(s) in 2007, 2 paper(s) in 2008, for a total of 23 research publications in total.

James D Jd Marks Author Information

LAST NAME: marks

FIRST NAME: James D

INITIALS: jd

AFFILIATION:

Papers

James D Marks's Publication Record

1. A structural perspective of the sequence variability within botulinum neurotoxin subtypes A1-A4. Year Published: 2006
Department of Molecular Biology, The Scripps Research Institute, 10550 N. Torrey Pines Road, La Jolla, CA 92037, USA.
2. A novel assay for monitoring internalization of nanocarrier coupled antibodies. Year Published: 2006
Department of Anesthesia, University of California San Francisco, San Francisco, CA 94110, USA. unielsen@merrimackpharma.com
3. Increased target specificity of anti-HER2 genospheres by modification of surface charge and degree of PEGylation. Year Published: 2006
California Pacific Medical Center, San Francisco, California 94115, USA.
4. Using phage display to select antibodies recognizing post-translational modifications independently of sequence context. Year Published: 2006
Department of Molecular and Cell Biology, University of California, Berkeley, California 94720, and Department of Anesthesia and Pharmaceutical Chemistry, San Francisco General Hospital 94110, USA.
5. Molecular evolution of antibody cross-reactivity for two subtypes of type A botulinum neurotoxin. Year Published: 2007
Department of Anesthesia and Pharmaceutical Chemistry, University of California, San Francisco Rm. 3C-38, San Francisco General Hospital, 1001 Potrero Ave., San Francisco, California 94110, USA.
6. Genetic diversity among Botulinum Neurotoxin-producing clostridial strains. Year Published: 2007
Bioscience, Theoretical Divisions, Los Alamos National Laboratory, Los Alamos, New Mexico 87545, USA.
7. Identification and characterization of tumor antigens by using antibody phage display and intrabody strategies. Year Published: 2007
8. Oxidant stress during simulated ischemia primes cardiomyocytes for cell death during reperfusion. Year Published: 2007
Department of Medicine, University of Chicago, Chicago, Illinois 60637, USA.
9. Impact of single-chain Fv antibody fragment affinity on nanoparticle targeting of epidermal growth factor receptor-expressing tumor cells. Year Published: 2007
Department of Anesthesia and Pharmaceutical Chemistry, University of California, San Francisco Rm 3C-38, San Francisco General Hospital, 1001 Potrero Ave, San Francisco, CA 94110, USA.
10. Regulation of antibody-dependent cellular cytotoxicity by IgG intrinsic and apparent affinity for target antigen. Year Published: 2007
Department of Medical Oncology, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA 19111, USA.
11. Recombinant full-length human IgG1s targeting hormone-refractory prostate cancer. Year Published: 2007
Department of Anesthesia, University of California at San Francisco, 1001 Potrero Avenue, 3C-38, San Francisco, CA 94110, USA. liub@anesthesia.ucsf.edu
12. Redirected activity of human antitumor chimeric immune receptors is governed by antigen and receptor expression levels and affinity of interaction. Year Published: 2007
Molecular Therapies Unit, Department of Experimental Oncology, Istituto Nazionale Tumori, Milan, Italy.
13. Anti-CD166 single chain antibody-mediated intracellular delivery of liposomal drugs to prostate cancer cells. Year Published: 2007
Department of Anesthesia, University of California at San Francisco, Room 3C38, 1001 Potrero Avenue, San Francisco, CA 94110, USA.
14. Assessment of hydraulic performance and biocompatibility of a MagLev centrifugal pump system designed for pediatric cardiac or cardiopulmonary support. Year Published: 2007
Levitronix LLC, Waltham, Massachusetts, USA.
15. Redirected activity of human antitumor chimeric immune receptors is governed by antigen and receptor expression levels and affinity of interaction. Year Published: 2007
Molecular Therapies Unit, Department of Experimental Oncology, Istituto Nazionale Tumori, Milan, Italy.
16. Analysis of the Neurotoxin Complex Genes in Clostridium botulinum A1-A4 and B1 Strains: BoNT/A3, /Ba4 and /B1 Clusters Are Located within Plasmids. Year Published: 2007
Integrated Toxicology Division, United States Army Medical Institute of Infectious Diseases, Fort Detrick, Maryland, United States of America.
17. Affinity thresholds for membrane fusion triggering by viral glycoproteins. Year Published: 2007
Molecular Medicine Program, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, USA.
18. Affinity thresholds for membrane fusion triggering by viral glycoproteins. Year Published: 2007
Molecular Medicine Program, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, USA.
19. Assessment of hydraulic performance and biocompatibility of a MagLev centrifugal pump system designed for pediatric cardiac or cardiopulmonary support. Year Published: 2007
Levitronix LLC, Waltham, Massachusetts, USA.
20. Effective Treatment of Established Human Breast Tumor Xenografts in Immunodeficient Mice with a Single Dose of the {alpha}-Emitting Radioisotope Astatine-211 Conjugated to Anti-HER2/neu Diabodies. Year Published: 2008
Authors' Affiliations: Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania.
21. Anti-CD166 single chain antibody-mediated intracellular delivery of liposomal drugs to prostate cancer cells. Year Published: 2007
Department of Anesthesia, University of California at San Francisco, Room 3C38, 1001 Potrero Avenue, San Francisco, CA 94110, USA.
22. Recombinant full-length human IgG1s targeting hormone-refractory prostate cancer. Year Published: 2007
Department of Anesthesia, University of California at San Francisco, 1001 Potrero Avenue, 3C-38, San Francisco, CA 94110, USA. liub@anesthesia.ucsf.edu
23. Molecular architecture of botulinum neurotoxin e revealed by single particle electron microscopy. Year Published: 2008
Section of Neurobiology, Division of Biological Sciences.